The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
Open accessAbstract
BACKGROUND: During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged and spread among humans in China. Data were lacking on the clinical characteristics of the infections caused by this virus. METHODS: Using medical charts, we collected data on 111 patients with laboratory-confirmed avian-origin influenza A (H7N9) infection through May 10, 2013. RESULTS: Of the 111 patients we studied, 76.6% were admitted to an intensive care unit (ICU), and 27.0% died. The median age was 61 years, and 42.3% were 65 years of age or older; 31.5% were female. A total of 61.3% of the patients had at least one underlying medical condition. Fever and cough were the most common presenting symptoms. On admission, 108 patients (97.3%) had findings consistent with pneumonia. Bilateral ground-glass opacities and consolidation were the typical radiologic findings. Lymphocytopenia was observed in 88.3% of patients, and thrombocytopenia in 73.0%. Treatment with antiviral drugs was initiated in 108 patients (97.3%) at a median of 7 days after the onset of illness. The median times from the onset of illness and from the initiation of antiviral therapy to a negative viral test result on real-time reverse-transcriptase-polymerase-chain-reaction assay were 11 days (interquartile range, 9 to 16) and 6 days (interquartile range, 4 to 7), respectively. Multivariate analysis revealed that the presence of a coexisting medical condition was the only independent risk factor for the acute respiratory distress syndrome (ARDS) (odds ratio, 3.42; 95% confidence interval, 1.21 to 9.70; P=0.02). CONCLUSIONS: During the evaluation period, the novel H7N9 virus caused severe illness, including pneumonia and ARDS, with high rates of ICU admission and death. (Funded by the National Natural Science Foundation of China and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
Self-citationInfluenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Avian Influenza A (H5N1) in 10 Patients in Vietnam
Hien, T. T., Liem, N. T., Dung, N. T., San, L. T., Mai, P. P., Chau, N. V. V., Suu, P. T., Dong, V. C., Mai, L. T. Q., Thi, N. T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040419 · Cited by 839
Chen, Y., Liang, W., Yang, S., Wu, N., Gao, H., Sheng, J., Yao, H., Wo, J., Fang, Q., Cui, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60903-4 · Cited by 827
Self-citationAntiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada
McGeer, A., Green, K. A., Plevneshi, A., Shigayeva, A., Siddiqi, N., Raboud, J., Low, D. E., & Toronto Invasive Bacterial Diseases Network (2007) · Clinical Infectious Diseases · doi:10.1086/523584 · Cited by 398
Human Disease from Influenza A (H5N1), Thailand, 2004
Chotpitayasunondh, T., Ungchusak, K., Hanshaoworakul, W., Chunsuthiwat, S., Sawanpanyalert, P., Kijphati, R., Lochindarat, S., Srisan, P., Suwan, P., Osotthanakorn, Y., et al. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1102.041061 · Cited by 378
Avian Influenza Virus Infections in Humans
Wong, S. S. Y., & Yuen, K.-Y. (2006) · Chest · doi:10.1378/chest.129.1.156 · Cited by 340
Past, Present, and Possible Future Human Infection with Influenza Virus A Subtype H7
Belser, J. A., Bridges, C. B., Katz, J. M., & Tumpey, T. M. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1506.090072 · Cited by 205
Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections
Uyeki, T. M., & Cox, N. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1304661 · Cited by 205
Cited by
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
“were used in a previous study to assess the severity of other serious infectious diseases, such as H7N9 infection.(16) Secondary end points were the rate of death and the time from symptom onset until the composite end point and until each component of the composite end point.”
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
“Similar to H7N9 patients [58], the elderly male with comorbidities and ARDS showed a higher death risk.”
ResultComorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Self-citationLiang, W., Liang, H., Ou, L., Chen, B., Chen, A., Li, C., Li, Y., Guan, W., Sang, L., Lu, J., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2033 · Cited by 1,387
Self-citationThe cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y.-H., & Yang, Z.-Q. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 716
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Self-citationEpidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
Li, Q., Zhou, L., Zhou, M., Chen, Z., Li, F., Wu, H., Xiang, N., Chen, E., Tang, F., Wang, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304617 · Cited by 688
Self-citationMusher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Co-infection with respiratory pathogens among COVID-2019 cases
Zhu, X., Ge, Y., Wu, T., Zhao, K., Chen, Y., Wu, B., Zhu, F., Zhu, B., & Cui, L. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198005 · Cited by 607
Zhao, D., Yao, F., Wang, L., Zheng, L., Gao, Y., Ye, J., Guo, F., Zhao, H., & Gao, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa247 · Cited by 488
Self-citation[Management of COVID-19: the Zhejiang experience].
Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., et al. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.02 · Cited by 452
Self-citationThe hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12470 · Cited by 438
Role of receptor binding specificity in influenza A virus transmission and pathogenesis
de Graaf, M., & Fouchier, R. A. M. (2014) · The EMBO Journal · doi:10.1002/embj.201387442 · Cited by 435
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q., Zhou, M., & Qu, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02752 · Cited by 420
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401
Self-citationNi, Y.-N., Chen, G., Sun, J., Liang, B.-M., & Liang, Z.-A. (2019) · Critical Care · doi:10.1186/s13054-019-2395-8 · Cited by 391
Biological features of novel avian influenza A (H7N9) virus
Zhou, J., Wang, D., Gao, R., Zhao, B., Song, J., Qi, X., Zhang, Y., Shi, Y., Yang, L., Zhu, W., et al. (2013) · Nature · doi:10.1038/nature12379 · Cited by 361
Self-citationCowling, B. J., Jin, L., Lau, E. H., Liao, Q., Wu, P., Jiang, H., Tsang, T. K., Zheng, J., Fang, V. J., Chang, Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61171-x · Cited by 338
Self-citationInfluenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine
Davlin, S. L., Blanton, L., Kniss, K., Mustaquim, D., Smith, S., Kramer, N., Cohen, J., Cummings, C. N., Garg, S., Flannery, B., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6522a3 · Cited by 328
Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks
Hui, D. S., Chow, B. K., Lo, T., Tsang, O. T. Y., Ko, F. W., Ng, S. S., Gin, T., & Chan, M. T. V. (2019) · European Respiratory Journal · doi:10.1183/13993003.02339-2018 · Cited by 328
Liang, W.-H., Guan, W.-J., Li, C.-C., Li, Y.-M., Liang, H.-R., Zhao, Y., Liu, X.-Q., Sang, L., Chen, R.-C., Tang, C.-L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00562-2020 · Cited by 303
Self-citationCao, B., Huang, Y., She, D., Cheng, Q., Fan, H., Tian, X., Xu, J., Zhang, J., Chen, Y., Shen, N., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12674 · Cited by 300
Self-citationIntegrative Physiology of Pneumonia
Quinton, L. J., Walkey, A. J., & Mizgerd, J. P. (2018) · Physiological Reviews · doi:10.1152/physrev.00032.2017 · Cited by 295
Bacterial co‐infections with SARS‐CoV‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 291
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Shen, L. W., Mao, H. J., Wu, Y. L., Tanaka, Y., & Zhang, W. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.016 · Cited by 285
Self-citationAngiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283
Self-citationWang, Z., Zhang, A., Wan, Y., Liu, X., Qiu, C., Xi, X., Ren, Y., Wang, J., Dong, Y., Bao, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321748111 · Cited by 272
Self-citationCorticosteroids as adjunctive therapy in the treatment of influenza
Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub2 · Cited by 264
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity
Yu, H., Cowling, B. J., Feng, L., Lau, E. H., Liao, Q., Tsang, T. K., Peng, Z., Wu, P., Liu, F., Fang, V. J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61207-6 · Cited by 252
Self-citation
Metadata
- Authors
- Gao, H.-N., Lu, H.-Z., Cao, B., Du, B., Shang, H., Gan, J.-H., Lu, S.-H., Yang, Y.-D., Fang, Q., Shen, Y.-Z., Xi, X.-M., Gu, Q., Zhou, X.-M., Qu, H.-P., Yan, Z., Li, F.-M., Zhao, W., Gao, Z.-C., Wang, G.-F., Ruan, L.-X., Wang, W.-H., Ye, J., Cao, H.-F., Li, X.-W., Zhang, W.-H., Fang, X.-C., He, J., Liang, W.-F., Xie, J., Zeng, M., Wu, X.-Z., Li, J., Xia, Q., Jin, Z.-C., Chen, Q., Tang, C., Zhang, Z.-Y., Hou, B.-M., Feng, Z.-X., Sheng, J.-F., Zhong, N.-S., & Li, L.-J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-06-13
- Volume
- 368
- Issue
- 24
- Pages
- 2277-2285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2159340685
- Cited by
- 651
- References
- 16
- FWCI
- 69.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.